Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The results were consistent: Trunk fat reduction: Tesamorelin-treated patients showed statistically significant reductions in trunk fat versus placebo at 26 weeks.[1] VAT reduction: Using cross-sectional CT imaging, tesamorelin produced approximately 1520% reductions in visceral adipose tissue compared to placebo.[1,2] Triglyceride improvement: Alongside fat reduction, tesamorelin improved triglyceride levels a key marker in metabolic syndrome.[2] Tesamorelin IGF-1 elevation: Treatment reliably elevated IGF-1 levels toward age-appropriate norms, confirming successful GH-axis stimulation.[1] These reductions occurred without dietary caloric restriction being mandated
For most patients without pre-existing cardiovascular conditions, a 57 bpm resting heart rate increase is clinically mild
2, May 2021, pp
And that was the initial kind of rationale
A mechanistic study has revealed that several proteins exhibit a significant correlation with changes in C-peptide levels, among which Glutathione Peroxidase 3 (GPX3) demonstrates the most pronounced inverse relationship with the fasting C-peptide/glucose ratio [35]
It is a synthetic peptide analogous to the receptors of the naturally occurring peptide called ghrelin (aka the GHS-R1a receptors)
US$ 24.00
US$ 27.01
US$ 22.82
,aspect=ignore)
US$ 29.19
US$ 24.72
